UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000009364
Receipt number R000011004
Scientific Title Long-term administration of fermented brown rice by Aspergillus oryzae in patients with ulcerative colitis
Date of disclosure of the study information 2012/11/24
Last modified on 2016/09/29 10:33:49

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Long-term administration of fermented brown rice by Aspergillus oryzae in patients with ulcerative colitis

Acronym

long-term administration of FBRA in patients with UC

Scientific Title

Long-term administration of fermented brown rice by Aspergillus oryzae in patients with ulcerative colitis

Scientific Title:Acronym

long-term administration of FBRA in patients with UC

Region

Japan


Condition

Condition

ulcerative colitis

Classification by specialty

Gastroenterology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To evaluate the usefulness and safety of long-term administration of fermented brown rice by Aspergillus oryzae (FBRA) in patients with ulcerative colitis (UC) in a single-arm study, and to determine the feasibility of performing a randomized study.

Basic objectives2

Safety,Efficacy

Basic objectives -Others


Trial characteristics_1

Confirmatory

Trial characteristics_2

Pragmatic

Developmental phase

Phase II


Assessment

Primary outcomes

The primary endpoint is the percent change in the time to normalization during the 2-year period after participation in the study compared to that during the 2-year period before participation.
The time to normalization is defined as the period from the onset of an abnormal C-reactive protein or white blood cell count in the peripheral blood to their normalization.

Key secondary outcomes

The secondary endpoints are the development of adverse events during the study, as well as various immunological parameters, clinical activity index (CAI), biochemical parameters, and endoscopic improvement after participation in the study compared to baseline.


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Historical

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Treatment

Type of intervention

Food

Interventions/Control_1

Patients receive 6 sachets (21 g) of FBRA, brown rice fermented by Aspergillus oryzae, daily (after every meal, 3 times daily) for 2 years.

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

Patients with UC who are to be comprehensively diagnosed based on clinical, endoscopic and histological findings.

Key exclusion criteria

Patients who have difficulty in eating or drinking.
Patients receiving corticosteroid or immunosuppressive agents (previous use is allowed).
Patients with a history of allergy to brown rice.
Patients who are determined by their attending physicians to be ineligible to participate in the study.

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Hideki Ishikawa MD, PhD

Organization

Graduate School of Medical Science, Kyoto Prefectural University of Medicine

Division name

Department of Molecular-Targeting Cancer

Zip code


Address

3-2-17-2F Imabashi, Chuo-ku, Osaka 541-0042, Japan

TEL

06-6202-5444

Email

cancer@gol.com


Public contact

Name of contact person

1st name
Middle name
Last name Hideki Ishikawa MD, PhD

Organization

Graduate School of Medical Science, Kyoto Prefectural University of Medicine

Division name

Department of Molecular-Targeting Cancer Prevention

Zip code


Address

3-2-17-2F Imabashi, Chuo-ku, Osaka 541-0042, Japan

TEL

06-6202-5444

Homepage URL


Email

cancer@gol.com


Sponsor or person

Institute

Graduate School of Medical Science, Kyoto
Prefectural University of Medicine

Institute

Department

Personal name



Funding Source

Organization

Graduate School of Medical Science, Kyoto
Prefectural University of Medicine

Organization

Division

Category of Funding Organization

Local Government

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

石川消化器内科(大阪府)


Other administrative information

Date of disclosure of the study information

2012 Year 11 Month 24 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled


Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2012 Year 09 Month 26 Day

Date of IRB


Anticipated trial start date

2012 Year 11 Month 24 Day

Last follow-up date


Date of closure to data entry


Date trial data considered complete

2016 Year 09 Month 29 Day

Date analysis concluded



Other

Other related information



Management information

Registered date

2012 Year 11 Month 19 Day

Last modified on

2016 Year 09 Month 29 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000011004


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name
2016/09/29 160825UMIN登録_FBRA長期投与試験 160916追加.xlsx